These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 6352267)

  • 1. Calcium channel blockers for primary and secondary Raynaud's phenomenon.
    Rirash F; Tingey PC; Harding SE; Maxwell LJ; Tanjong Ghogomu E; Wells GA; Tugwell P; Pope J
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD000467. PubMed ID: 29237099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raynaud's phenomenon (secondary).
    Herrick A
    BMJ Clin Evid; 2008 Sep; 2008():. PubMed ID: 19445801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy of Raynaud's phenomenon.
    Belch JJ; Ho M
    Drugs; 1996 Nov; 52(5):682-95. PubMed ID: 9118818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and laboratory effects of nifedipine in Raynaud's phenomenon.
    Hawkins SJ; Black CM; Hall ND; McGregor A; Ring EF; Maddison PJ
    Rheumatol Int; 1986; 6(2):85-8. PubMed ID: 3764307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and rheological effects of nifedipine in Raynaud's phenomenon.
    Waller DG; Challenor VF; Francis DA; Roath OS
    Br J Clin Pharmacol; 1986 Oct; 22(4):449-54. PubMed ID: 3533127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.
    Sorkin EM; Clissold SP; Brogden RN
    Drugs; 1985 Sep; 30(3):182-274. PubMed ID: 2412780
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of nifedipine in hypertension and Raynaud's phenomenon.
    Kiowski W; Erne P; Bühler FR
    Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():935-40. PubMed ID: 2076403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium channel blockers for primary Raynaud's phenomenon.
    Ennis H; Hughes M; Anderson ME; Wilkinson J; Herrick AL
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD002069. PubMed ID: 26914257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium channel blockers for primary Raynaud's phenomenon.
    Ennis H; Anderson ME; Wilkinson J; Herrick AL
    Cochrane Database Syst Rev; 2014 Jan; (1):CD002069. PubMed ID: 24482037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium entry blocking agents in digital vasospasm (Raynaud's phenomenon).
    Kahan A; Weber S; Amor B; Menkes CJ; Saporta L; Hodara M; Guerin F; Degeorges M
    Eur Heart J; 1983 May; 4 Suppl C():123-9. PubMed ID: 6352267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nifedipine and Raynaud's phenomenon associated with connective tissue diseases.
    Kahan A; Weber S; Amor B; Menkes CJ; Hodara M; Degeorges M
    Int Angiol; 1985; 4(2):221-3. PubMed ID: 3831143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Controlled study of nifedipine in the treatment of Raynaud's phenomenon].
    Kahan A; Weber S; Amor B; Saporta L; Hodara M; Degeorges M
    Rev Rhum Mal Osteoartic; 1982 Apr; 49(5):337-43. PubMed ID: 6285445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.
    Rademaker M; Cooke ED; Almond NE; Beacham JA; Smith RE; Mant TG; Kirby JD
    BMJ; 1989 Mar; 298(6673):561-4. PubMed ID: 2467711
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.